Literature DB >> 6324699

Human parvovirus, fifth disease, and marrow aplasia.

D A Tyrrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6324699      PMCID： PMC1628548          DOI： 10.1136/adc.59.3.197

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  7 in total

1.  Human parvovirus, the cause of erythema infectiosum (fifth disease)?

Authors:  M J Anderson; S E Jones; S P Fisher-Hoch; E Lewis; S M Hall; C L Bartlett; B J Cohen; P P Mortimer; M S Pereira
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

2.  Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency.

Authors:  J R Duncan; C B Potter; M D Cappellini; J B Kurtz; M J Anderson; D J Weatherall
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

3.  Parvovirus infections and hypoplastic crisis in sickle-cell anaemia.

Authors:  J R Pattison; S E Jones; J Hodgson; L R Davis; J M White; C E Stroud; L Murtaza
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

4.  High-density lipoprotein and coronary risk factors in normal men.

Authors:  P Williams; D Robinson; A Bailey
Journal:  Lancet       Date:  1979-01       Impact factor: 79.321

5.  Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent.

Authors:  G R Serjeant; J M Topley; K Mason; B E Serjeant; J R Pattison; S E Jones; R Mohamed
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

6.  Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia.

Authors:  K R Rao; A R Patel; M J Anderson; J Hodgson; S E Jones; J R Pattison
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

7.  Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus.

Authors:  J Summers; S E Jones; M J Anderson
Journal:  J Gen Virol       Date:  1983-11       Impact factor: 3.891
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.